BIGLARI CAPITAL CORP.: BAUSCH HEALTH COS INC (BHC): Quarterly 13F Position History
As of Q1 2026, BIGLARI CAPITAL CORP. reported 41,070 shares of BAUSCH HEALTH COS INC (BHC), worth $221.8K and representing 0.0% of its 13F equity book. The position first appeared in Q3 2018 and has been disclosed across 31 13F-HR filings in Pactolio's tracked window.
- 41,070Shares Held (Latest Filing)
- $221.8KReported Market Value (Latest Filing)
- 0.0%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- -$63.7KQuarter-over-Quarter Value Change
- 395,000Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 31 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 41,070 | 0 | — | $221.8K | 0.0% | $5.4 |
| Q4 2025 | 41,070 | 0 | — | $285.4K | 0.0% | $7.0 |
| Q3 2025 | 41,070 | 0 | — | $264.9K | 0.0% | $6.5 |
| Q2 2025 | 41,070 | 59,000 | -59.0% | $273.5K | 0.0% | $6.7 |
| Q1 2025 | 100,070 | 194,930 | -66.1% | $647.5K | 0.1% | $6.5 |
| Q4 2024 | 295,000 | 100,000 | -25.3% | $2.4M | 0.3% | $8.1 |
| Q3 2024 | 395,000 | 0 | — | $3.2M | 0.5% | $8.2 |
| Q2 2024 | 395,000 | 0 | — | $2.8M | 0.4% | $7.0 |
| Q1 2024 | 395,000 | 0 | — | $4.2M | 0.6% | $10.6 |
| Q4 2023 | 395,000 | 0 | — | $3.2M | 0.5% | $8.0 |
| Q3 2023 | 395,000 | 0 | — | $3.2M | 0.5% | $8.2 |
| Q2 2023 | 395,000 | 0 | — | $3.2M | 0.4% | $8.0 |
| Q1 2023 | 395,000 | 0 | — | $3.2M | 0.4% | $8.1 |
| Q4 2022 | 395,000 | 0 | — | $2.5M | 0.4% | $6.3 |
| Q3 2022 | 395,000 | 0 | — | $2.7M | 0.6% | $6.9 |
| Q2 2022 | 395,000 | 0 | — | $3.3M | 0.8% | $8.4 |
| Q1 2022 | 395,000 | 0 | — | $9.0M | 1.6% | $22.9 |
| Q4 2021 | 395,000 | 0 | — | $10.9M | 1.7% | $27.6 |
| Q3 2021 | 395,000 | 0 | — | $11.0M | 1.5% | $27.9 |
| Q2 2021 | 395,000 | 0 | — | $11.6M | 1.6% | $29.3 |
| Q1 2021 | 395,000 | 0 | — | $12.5M | 1.8% | $31.7 |
| Q4 2020 | 395,000 | 0 | — | $8.2M | 1.5% | $20.8 |
| Q3 2020 | 395,000 | 0 | — | $6.1M | 1.2% | $15.5 |
| Q2 2020 | 395,000 | 0 | — | $7.2M | 1.7% | $18.3 |
| Q1 2020 | 395,000 | 0 | — | $6.1M | 2.1% | $15.5 |
| Q4 2019 | 395,000 | 0 | — | $11.8M | 2.0% | $29.9 |
| Q3 2019 | 395,000 | 0 | — | $8.6M | 1.5% | $21.9 |
| Q2 2019 | 395,000 | 0 | — | $10.0M | 1.4% | $25.2 |
| Q1 2019 | 395,000 | 0 | — | $9.8M | 1.2% | $24.7 |
| Q4 2018 | 395,000 | 0 | — | $7.3M | 0.8% | $18.5 |
| Q3 2018 | 395,000 | — | — | $10.1M | 1.0% | $25.7 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did BIGLARI CAPITAL CORP. first disclose a BHC position in 13F-HR filings?
BIGLARI CAPITAL CORP. first reported BAUSCH HEALTH COS INC (BHC) on its 13F-HR filing for the period ending 2018-09-30 (Q3 2018). The position has appeared on 31 reported quarters within Pactolio's tracked window.
What was BIGLARI CAPITAL CORP.'s most recent quarter-over-quarter share-count change in BHC?
BIGLARI CAPITAL CORP. held the same 41,070 shares of BHC between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent BIGLARI CAPITAL CORP.'s cost basis in BHC?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.